Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

STORM CHASER Trial Fails to Meet Primary Endpoint in Post-Exposure Prevention of Symptomatic COVID-19

americanpharmaceuticalreviewJune 17, 2021

Tag: STORM CHASER , AZD7442 , SARS-CoV-2 , COVID-19 , AstraZeneca

PharmaSources Customer Service